https://www.thebostonexaminer.com/article/915212085-choroideremia-research-foundation-announces-june-30-research-grant-application-deadline The Boston Examiner en PressRelease 2026-05-26T18:14:44+00:00 Choroideremia Research Foundation Announces June 30 Research Grant Application Deadline https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867463-june-30-grant-1280x720.png https://www.thebostonexaminer.com/article/913637191-innovative-life-changing-tms-therapy-at-northeast-health-services-boston-government-center-clinic The Boston Examiner en PressRelease 2026-05-26T16:15:00+00:00 Innovative, Life Changing TMS Therapy at Northeast Health Services' Boston Government Center Clinic https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861076-tms1-1024x769.png https://www.thebostonexaminer.com/article/915186748-pos-supply-solutions-expands-product-line-rebrands-pos-sticky-labels-as-quickstick-receipt-labels-for-restaurants-qsrs The Boston Examiner en PressRelease 2026-05-26T15:02:45+00:00 POS Supply Solutions Expands Product Line & Rebrands POS Sticky Labels as QuickStick Receipt Labels for Restaurants/QSRs https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867248-quickstick-receipt-labels-on-fo-3164x1779.jpeg https://www.thebostonexaminer.com/article/914233987-hanover-high-school-senior-ava-khouri-publishes-inspiring-children-s-book-the-apple-of-my-pie The Boston Examiner en PressRelease 2026-05-26T14:30:00+00:00 Hanover High School Senior Ava Khouri Publishes Inspiring Children’s Book: The Apple of My Pie https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851063-aomp-cover-2338x2338.jpeg https://www.thebostonexaminer.com/article/915181417-the-cottagers-incorporated-of-martha-s-vineyard-celebrate-70-years-of-service-and-giving The Boston Examiner en PressRelease 2026-05-26T14:25:29+00:00 The Cottagers Incorporated of Martha's Vineyard Celebrate 70 Years of Service and Giving https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867143-70th-anniversary-group-photo-985x337.png https://www.thebostonexaminer.com/article/911838942-this-men-s-mental-health-month-boston-gynecomastia-specialists-highlights-gynecomastia-s-impact-on-men-s-mental-health The Boston Examiner en PressRelease 2026-05-26T14:00:00+00:00 This Men's Mental Health Month, Boston Gynecomastia Specialists highlights Gynecomastia’s impact on men’s mental health https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24852300-male-breast-reduction-results-a-961x1274.png https://www.thebostonexaminer.com/article/914901616-new-england-patriots-rb-treveyon-henderson-stars-in-announcement-video-as-gripped-book-series-heads-to-television The Boston Examiner en PressRelease 2026-05-26T14:00:00+00:00 New England Patriots RB TreVeyon Henderson Stars in Announcement Video as Gripped Book Series Heads to Television https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24866022-stacy-trey-filming-1182x886.jpeg https://www.thebostonexaminer.com/article/915168763-ultrasight-study-shows-novices-achieve-diagnostic-quality-cardiac-ultrasound-after-one-day-of-ai-guided-training The Boston Examiner en PressRelease 2026-05-26T13:12:40+00:00 UltraSight™ Study Shows Novices Achieve Diagnostic-Quality Cardiac Ultrasound After One Day of AI-Guided Training https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22432389-ultrasight-logo-3442x1396.png https://www.thebostonexaminer.com/article/913662712-stanford-study-finds-contingency-management-highly-cost-effective-for-methamphetamine-use-disorder The Boston Examiner en PressRelease 2026-05-26T13:00:00+00:00 Stanford Study Finds Contingency Management Highly Cost-Effective for Methamphetamine Use Disorder https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24539771-cmi-logo-1650x732.jpeg https://www.thebostonexaminer.com/article/915261461-caswell-plumbing-and-heating-recognized-as-top-rated-plumber-in-framingham-ma-by-best-of-2026-businessrate The Boston Examiner en PressRelease 2026-05-26T20:32:00+00:00 Caswell Plumbing and Heating Recognized as Top Rated Plumber in Framingham, MA by Best of 2026 BusinessRate https://pressranger.s3.us-west-1.amazonaws.com/3321366/Caswell-Plumbing-and-Heating-in-Framinham%2C-MA---master-plumber-tim-caswell.png https://www.thebostonexaminer.com/article/915249810-destination-xl-group-inc-recommends-dxl-shareholders-reject-zodiac-partners-ii-s-tender-offer-and-not-tender-their-shares The Boston Examiner en PressRelease 2026-05-26T20:25:00+00:00 Destination XL Group, Inc. Recommends DXL Shareholders Reject Zodiac Partners II’s Tender Offer And NOT Tender Their Shares https://ml.globenewswire.com/media/6ecdc08b-a991-4864-bec7-55382a7936d8/small/dxl-b-t-2020-jpg.jpg https://www.thebostonexaminer.com/article/915249337-spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences The Boston Examiner en PressRelease 2026-05-26T20:10:00+00:00 Spyre Therapeutics to Participate in Upcoming June Investor Conferences https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.thebostonexaminer.com/article/915249352-jade-biosciences-announces-first-participant-dosed-in-first-in-human-phase-1-clinical-trial-of-jade201-a-novel-half-life-extended-afucosylated The Boston Examiner en PressRelease 2026-05-26T20:05:00+00:00 Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://www.thebostonexaminer.com/article/915249364-cargurus-to-present-at-the-bofa-securities-2026-global-technology-conference The Boston Examiner en PressRelease 2026-05-26T20:05:00+00:00 CarGurus to Present at the BofA Securities 2026 Global Technology Conference https://ml.globenewswire.com/media/5e9ed825-143d-405a-9794-acd1a1ded2cc/small/cg-logo-2025-small-png.png https://www.thebostonexaminer.com/article/915249585-kailera-reports-first-quarter-2026-financial-results-and-provides-clinical-data-updates The Boston Examiner en PressRelease 2026-05-26T20:02:00+00:00 Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://www.thebostonexaminer.com/article/915249554-apogee-therapeutics-to-host-conference-call-to-report-part-b-16-week-data-from-the-phase-2-apex-trial-of-zumilokibart-in-patients-with The Boston Examiner en PressRelease 2026-05-26T20:01:00+00:00 Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026 https://ml.globenewswire.com/media/c7ab4c17-2e41-4560-b2a2-70d0c23c8c8b/small/apogeelogo-png.png https://www.thebostonexaminer.com/article/915249667-molecular-partners-to-present-at-td-cowen-s-7th-annual-oncology-innovation-summit The Boston Examiner en PressRelease 2026-05-26T20:00:00+00:00 Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg https://www.thebostonexaminer.com/article/915237931-gordon-brothers-acquires-radley-brand The Boston Examiner en PressRelease 2026-05-26T18:48:25+00:00 Gordon Brothers Acquires Radley Brand https://ml.globenewswire.com/media/ODllMDQxZWUtMzIyZS00NjI0LThkZjMtYTY4M2Q0NTU4M2JiLTExMTAxODYtMjAyNi0wNS0yNi1lbg==/tiny/Gordon-Brothers.png https://www.thebostonexaminer.com/article/915192074-astra-tower-achieves-leed-gold-certification-advancing-sustainable-living-in-salt-lake-city The Boston Examiner en PressRelease 2026-05-26T14:34:07+00:00 Astra Tower Achieves LEED Gold Certification, Advancing Sustainable Living in Salt Lake City https://ml.globenewswire.com/media/ODEyMDUwNWMtOGRmMS00NGE5LWIzYjktZTRjNzUyM2I2MTJmLTUwMDE2MjkwMC0yMDI2LTA1LTI2LWVu/tiny/Kensington-Investment-Company.png https://www.thebostonexaminer.com/article/915183417-the-value-of-extending-the-diablo-canyon-nuclear-plant-s-operating-life The Boston Examiner en PressRelease 2026-05-26T14:05:00+00:00 The Value of Extending the Diablo Canyon Nuclear Plant’s Operating Life https://ml.globenewswire.com/media/Y2VlNzM4ZTktODIzYS00YTAxLTk1ZDktMGJkODJmNmJjZWRmLTEyNzMzMTEtMjAyNi0wNS0yNi1lbg==/tiny/MIT-Sloan-School-of-Management.png https://www.thebostonexaminer.com/article/915175871-mit-sloan-executive-education-expands-portfolio-of-ai-courses-and-certifications The Boston Examiner en PressRelease 2026-05-26T13:15:00+00:00 MIT Sloan Executive Education Expands Portfolio of AI Courses and Certifications https://ml.globenewswire.com/media/YTY0YzExZjMtYjliYS00OTRkLWJkY2QtODkyYmZhZDZhMTk0LTEzMTMzNzgtMjAyNi0wNS0yNi1lbg==/tiny/MIT-Sloan-Executive-Education.png https://www.thebostonexaminer.com/article/915176613-editas-medicine-announces-pricing-of-up-to-319-4-million-public-offering The Boston Examiner en PressRelease 2026-05-26T13:05:00+00:00 Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://www.thebostonexaminer.com/article/915176270-nift-adds-former-disney-and-espn-executive-as-commerce-media-platform-accelerates-growth The Boston Examiner en PressRelease 2026-05-26T13:00:00+00:00 Nift Adds Former Disney and ESPN Executive as Commerce Media Platform Accelerates Growth https://ml.globenewswire.com/media/52123161-2250-400d-8f24-2cc78e6a5dc6/medium/nift-appoints-marc-mallett-as-senior-partner-sales-director.jpg https://www.thebostonexaminer.com/article/915168432-nodthera-announces-the-publication-and-presentation-of-cardiometabolic-clinical-data-supporting-the-potential-of-ruvonoflast-to-treat-inflammation-at The Boston Examiner en PressRelease 2026-05-26T12:45:00+00:00 NodThera Announces the Publication and Presentation of Cardiometabolic Clinical Data Supporting the Potential of Ruvonoflast to Treat Inflammation at the Source https://ml.globenewswire.com/media/47e7b50f-0ca3-4bf3-8a6b-753432486e1c/small/nodthera-logo-full-color-rgb-high-png.png https://www.thebostonexaminer.com/article/915168800-microbot-medical-receives-its-first-international-regulatory-approval-for-the-commercialization-of-the-liberty-endovascular-robotic-system The Boston Examiner en PressRelease 2026-05-26T12:30:00+00:00 Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://www.thebostonexaminer.com/article/915160263-rhythm-pharmaceuticals-announces-participation-in-upcoming-investor-conferences The Boston Examiner en PressRelease 2026-05-26T12:00:00+00:00 Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.thebostonexaminer.com/article/915160471-after-7-million-investigations-in-production-7ai-widens-the-gap-in-agentic-security-with-plaid-elite-and-100-new-ai-jobs-in-boston The Boston Examiner en PressRelease 2026-05-26T12:00:00+00:00 After 7 Million Investigations in Production, 7AI Widens the Gap in Agentic Security with PLAID ELITE and 100 New AI Jobs in Boston https://ml.globenewswire.com/media/49a75202-5661-422f-b6dd-4be441d0c02c/small/7ai-logo-black-png.png https://www.thebostonexaminer.com/article/915160612-nano-dimension-issues-letter-to-shareholders The Boston Examiner en PressRelease 2026-05-26T12:00:00+00:00 Nano Dimension Issues Letter to Shareholders https://ml.globenewswire.com/media/dd1b96fc-0b19-4125-bdcb-867c52c8f415/small/logo-nd-nw-png.png https://www.thebostonexaminer.com/article/915160621-vicor-corporation-revises-q2-2026-revenue-guidance The Boston Examiner en PressRelease 2026-05-26T12:00:00+00:00 Vicor Corporation Revises Q2 2026 Revenue Guidance https://ml.globenewswire.com/media/55117480-366f-4254-a0c3-1c89d863eb54/small/1200x628-4x-png.png https://www.thebostonexaminer.com/article/915160575-dyne-therapeutics-announces-submission-of-biologics-license-application-bla-to-u-s-fda-for-z-rostudirsen-in-exon-51-duchenne-muscular-dystrophy The Boston Examiner en PressRelease 2026-05-26T11:30:00+00:00 Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD) https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://www.thebostonexaminer.com/article/915153348-jade-biosciences-announces-first-participant-dosed-in-phase-2-juniper-clinical-trial-of-jade101-in-iga-nephropathy The Boston Examiner en PressRelease 2026-05-26T11:00:00+00:00 Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://www.thebostonexaminer.com/article/915153437-corbus-pharmaceuticals-reports-updated-crb-701-phase-1-2-clinical-data-demonstrating-robust-activity-in-2l-oropharyngeal-and-cervical-cancers The Boston Examiner en PressRelease 2026-05-26T11:00:00+00:00 Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.thebostonexaminer.com/article/915153443-climb-bio-to-present-on-clym116-and-budoprutug-programs-at-european-renal-association-era-congress-2026 The Boston Examiner en PressRelease 2026-05-26T11:00:00+00:00 Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026 https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://www.thebostonexaminer.com/article/915153470-cullinan-therapeutics-to-host-immunology-day-to-showcase-promising-initial-clinical-data-in-autoimmune-diseases-for-cln-978-a-cd19-t-cell-engager The Boston Examiner en PressRelease 2026-05-26T11:00:00+00:00 Cullinan Therapeutics to Host Immunology Day to Showcase Promising Initial Clinical Data in Autoimmune Diseases for CLN-978, a CD19 T Cell Engager, and Velinotamig, a BCMA T Cell Engager https://ml.globenewswire.com/media/3f4113d3-b651-4c00-bd96-c1ff9384b1de/small/cullinan-logo-rgb-clr-png.png https://www.thebostonexaminer.com/article/915145961-editas-medicine-announces-proposed-public-offering The Boston Examiner en PressRelease 2026-05-26T10:15:03+00:00 Editas Medicine Announces Proposed Public Offering https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://www.thebostonexaminer.com/article/915139253-editas-medicine-presents-edit-401-preclinical-data-demonstrating-robust-reductions-in-ldl-c-lp-a-and-apob-in-non-human-primates-at-the-94th The Boston Examiner en PressRelease 2026-05-26T10:01:00+00:00 Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://www.thebostonexaminer.com/article/915139265-tycho-ai-validates-halley-vtol-uas-with-successful-c-uas-and-one-way-attack-demonstrations-at-t-rex-26-2 The Boston Examiner en PressRelease 2026-05-26T10:00:00+00:00 Tycho.AI Validates Halley VTOL UAS with Successful C-UAS and One-Way Attack Demonstrations at T-REX 26-2 https://ml.globenewswire.com/media/01f322ae-b547-4672-a5f6-624854b088da/medium/halley-soars-at-t-rex-26-2.jpg https://www.thebostonexaminer.com/article/915139244-wind-turbine-blade-recycling-market-to-reach-158-9-billion-by-2030-driven-by-massive-wave-of-turbine-decommissioning The Boston Examiner en PressRelease 2026-05-26T09:32:00+00:00 Wind Turbine Blade Recycling Market to Reach $158.9 Billion by 2030, Driven by Massive Wave of Turbine Decommissioning https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.thebostonexaminer.com/article/914948997-nanjing-university-of-information-science-and-technology-study-reveals-evolving-summer-aerosol-pollution The Boston Examiner en PressRelease 2026-05-25T12:17:01+00:00 Nanjing University of Information Science and Technology Study Reveals Evolving Summer Aerosol Pollution https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24866243-secondary-aerosols-in-urban-ai-500x333.jpeg https://www.thebostonexaminer.com/article/914942287-black-lab-alarm-reports-rising-demand-for-boston-security-systems The Boston Examiner en PressRelease 2026-05-25T11:07:28+00:00 Black Lab Alarm Reports Rising Demand for Boston Security Systems https://www.thebostonexaminer.com/article/904782160-access-fixtures-launches-new-apol-solar-led-flagpole-lights-with-360-illumination The Boston Examiner en PressRelease 2026-05-25T10:00:00+00:00 Access Fixtures Launches New APOL Solar LED Flagpole Lights with 360° Illumination https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24829869-apol-18-watt-led-solar-flagpole-1080x1080.png https://www.thebostonexaminer.com/article/914749100-massachusetts-author-roan-miles-releases-the-truth-within-a-powerful-children-s-book-for-mental-health-awareness-month The Boston Examiner en PressRelease 2026-05-25T05:06:23+00:00 Massachusetts Author Roan Miles Releases The Truth Within, A Powerful Children’s Book for Mental Health Awareness Month https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24865577-the-truth-within-by-author-ro-900x1357.jpeg